Trademark: 87511234
Word

Status
Dead
Status Code
606
Status Date
Monday, August 3, 2020
Serial Number
87511234
Mark Type
2000
Filing Date
Thursday, June 29, 2017
Published for Opposition
Tuesday, November 7, 2017
Abandoned Date
Monday, August 3, 2020

Trademark Owner History
AltiBio, Inc. - Owner At Publication

Classifications
5 Therapeutic pharmaceuticals for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of oncological diseases and disorders, kidney diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, and diseases and disorders in the field of immunology
Color is not claimed as a feature of the mark.
The mark consists of a stylized design of growing molecules.

Trademark Events
Aug 3, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 3, 2020
Abandonment - No Use Statement Filed
Dec 11, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2019
Extension 4 Granted
Dec 9, 2019
Extension 4 Filed
Dec 9, 2019
Teas Extension Received
Jun 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Jun 4, 2019
Extension 3 Granted
Jun 4, 2019
Extension 3 Filed
Jun 4, 2019
Teas Extension Received
Nov 9, 2018
Notice Of Approval Of Extension Request E-Mailed
Nov 7, 2018
Extension 2 Granted
Nov 7, 2018
Extension 2 Filed
Nov 7, 2018
Teas Extension Received
Jun 23, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 21, 2018
Extension 1 Granted
Jun 21, 2018
Extension 1 Filed
Jun 21, 2018
Teas Extension Received
Jan 2, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 7, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 7, 2017
Published For Opposition
Oct 18, 2017
Notification Of Notice Of Publication E-Mailed
Sep 26, 2017
Approved For Pub - Principal Register
Sep 26, 2017
Assigned To Examiner
Jul 11, 2017
Notice Of Design Search Code E-Mailed
Jul 8, 2017
New Application Office Supplied Data Entered In Tram
Jul 3, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24